Lupin Ltd., one of India’s leading pharmaceutical companies, has entered a strategic partnership with Gan & Lee Pharmaceuticals to launch a novel obesity drug in the Indian market. The collaboration aims to combine Lupin’s strong distribution network and regulatory expertise with Gan & Lee’s innovative formulation, addressing the growing prevalence of obesity and related metabolic disorders in India.